Novel Therapeutic Candidate Targeting VSTM-1(NextCure)

N/A

Report date: 2024/01/19 15:18:59

Base Information

Drug NameNovel Therapeutic Candidate Targeting VSTM-1(NextCure)
Drug Alias NameVSTM-1 Agonist mAb Therapy(NextCure)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionV-Set And Transmembrane Domain-Containing Protein 1 agonists
TargetsV-Set And Transmembrane Domain-Containing Protein 1
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNextcure Inc
China Registration ClassN/A

Develop Information

Active CompaniesNextcure Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A